General Anesthesia
📧 Sign up to get email alerts when something new happens for General Anesthesia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-10-16FDA Approved: SEVOFLURANE — Supplemental Application (Piramal Critical Care Inc)
The FDA approved a supplemental application for Sevoflurane from Piramal Critical Care Inc.
-
FDA approval · 2024-10-03FDA Approved: METHOHEXITAL SODIUM — Original Application (ONESOURCE SPECIALTY PHARMA LIMITED)
FDA approved a generic methohexital sodium product for anesthesia induction under ANDA215488 by Onesource Specialty Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Comparison of the Anaesthetic Gases in Maintainance of General Anaesthesia in Paediatrics [Phase 1, Phase 2]
A clinical trial update comparing anaesthetic gases for maintaining general anaesthesia in pediatric patients, spanning Phase 1 and Phase 2,…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Postoperative Sugammadex After COVID-19 [Phase 4]
Phase 4 clinical trial update examining postoperative use of sugammadex in patients with or undergoing COVID-19-related anesthesia.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children [Phase 2]
Phase 2 trial evaluating pharmacokinetic-pharmacodynamic analysis of sugammadex in children has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-11-01FDA Approved: ULTANE — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for ULTANE (sevoflurane) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Effects of Intravenous Lidocaine on ED50, ED95 and NTI Values of Propofol Induced Unconsciousness [Phase 1, Phase 2]
Clinical trial investigating the effects of intravenous lidocaine on ED50, ED95, and NTI values of propofol-induced unconsciousness in gener…
-
FDA approval · 2020-11-03FDA Approved: BREVITAL SODIUM — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Brevital Sodium (methohexital sodium) from Par Health USA, LLC.
-
FDA approval · 2020-10-13FDA Approved: REMIFENTANIL HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma's original-application ANDA for remifentanil hydrochloride, a generic opioid analgesic used to provide anesthesia during …
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Remimazolam Phase II Cardiac Anesthesia Study [Phase 2]
Phase II clinical trial update for remimazolam in cardiac anesthesia has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) [Phase 3]
Phase 3 trial assessing safety and efficacy of sugammadex in participants with or history of pulmonary disease; study completed and results …
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia [Phase 3]
A Phase 3 comparative trial evaluating the efficacy and safety of remimazolam versus propofol in patients undergoing elective surgery with g…
-
FDA approval · 2018-03-07FDA Approved: ETOMIDATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Etomidate from Hikma Pharmaceuticals USA Inc. under ANDA 202354.
-
FDA approval · 2017-12-22FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for propofol from Sagent Pharmaceuticals, indicating an expanded or updated regulatory approval for …
-
FDA approval · 2017-04-27FDA Approved: FORANE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for FORANE (isoflurane) submitted by Baxter Healthcare Corporation.
-
FDA approval · 2017-04-27FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Manual Administration of Propofol-remifentanil Versus Dual Closed-loop Using Bispectral Index as the Control Variable [Phase 4]
A Phase 4 trial comparing manual administration of propofol-remifentanil to a dual closed-loop BIS-controlled system in general anesthesia h…
-
FDA approval · 2016-07-05FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Propofol filed by Sagent Pharmaceuticals (ANDA075102).
-
FDA approval · 2016-02-25FDA Approved: ETOMIDATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original application for etomidate from Hikma Pharmaceuticals USA Inc., making a generic etomidate available for induction …
-
FDA approval · 2013-09-27FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation, updating labeling details for the anesthe…
-
FDA approval · 2013-06-16FDA Approved: NITROUS OXIDE — Original Application (United States Welding, Inc.)
FDA approves the original application for Nitrous Oxide from United States Welding, Inc., confirming its use as an inhaled anesthetic.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Combination of Magnesium and Lidocaine for the Pretreatment of Pain That is Caused by the Injection of Propofol [Phase 4]
Phase 4 trial evaluating magnesium and lidocaine pretreatment to reduce pain from propofol injection; completed with posted results in 2012.
-
FDA approval · 2010-11-22FDA Approved: QUELICIN — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for Quelicin (succinylcholine chloride) submitted by Hospira, Inc., updating the existing produc…
-
FDA approval · 2009-08-10FDA Approved: TERRELL — Supplemental Application (Piramal Critical Care Inc)
FDA approved a supplemental application for TERRELL (isoflurane) from Piramal Critical Care Inc, updating the product's approval for use as …
-
FDA approval · 2008-11-26FDA Approved: ROCURONIUM BROMIDE — Original Application (Mylan Institutional LLC)
FDA approves Rocuronium bromide under an Original Application (ANDA) for generic use as a neuromuscular blocker to facilitate tracheal intub…